Why Pfizer's Stock Price Isn't Reflecting Its True Value

Group 1 - Pfizer released financial results for the fourth quarter of 2024, surpassing both internal expectations and those of Wall Street analysts [1] Group 2 - Allka Research has over two decades of experience in investment, focusing on uncovering undervalued assets in various sectors including ETFs, commodities, technology, and pharmaceuticals [2] - The firm emphasizes a conservative approach to investment, aiming to deliver substantial returns and strategic insights to clients [2] - Allka Research seeks to simplify investment strategies, making them accessible to both seasoned and novice investors [2] - The mission of Allka Research includes contributing analyses and perspectives to the Seeking Alpha community, fostering a knowledgeable investor base [2]